ストックスクリーナーアプリを入手
4.28
3.17%
-0.14
Basel Medical Group Ltd (BMGL) 最新ニュース
Basel Medical Group announces leadership shake-up By Investing.com - Investing.com Canada
Basel Medical Group Announces Leadership Changes in April 2025 - TipRanks
Basel Medical Group Ltd -Resignation Of Raymond Cheung As Chief Executive Officer - marketscreener.com
WORK Medical Technology Group receives Nasdaq notification - Medical Buyer
Basel Medical Group acquires Bethesda Medical - Medical Buyer
SEA Digest: Basel to buy SG's Bethesda Medical; Indonesia's Surge bags NTT East investment - DealStreetAsia
Bethesda Medical acquired by Basel Medical - Crunchbase
Basel Medical to acquire Bethesda Medical, terms undisclosed - TipRanks
Basel Medical Group Expands with Acquisition of Bethesda Medical - TipRanks
Basel Medical Group to Acquire Bethesda Medical in Southeast Asia Expansion Push - marketscreener.com
Basel Medical to buy Singapore-based Bethesda Medical - Seeking Alpha
Basel Medical To Acquire Singapore's Bethesda Medical For Undisclosed Terms - Nasdaq
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - The Manila Times
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia - GlobeNewswire Inc.
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Pre-market Movers: VERO, WORX, GFR, ALTG, QLGN… - RTTNews
Venus Shines, VRDN On Track For BLA Submission, AVDL On Watch - RTTNews
Basel Medical Group Appoints Founder Raymond Fung to Board - TipRanks
OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer - PR Newswire
Oscar-winning Palestinian director ‘attacked by Israeli settlers and detained’ - North Wales Chronicle
Palestinian Director of 'No Other Land' Attacked by Settler Mob, Arrested by Soldiers, Israeli Co-director Says - Haaretz
Basel Medical Group Completes Overallotment Option Exercise in IPO - TipRanks
Basel Medical Group Ltd Announces Exercise of Overallotment Option - The Manila Times
Orchid Island Capital Announces March 2025 Monthly Dividend and February 28, 2025 RMBS Portfolio Characteristics - The Manila Times
Basel Medical Group Ltd Completes Full Exercise of Overallotment Option in IPO, Raising Additional $1.32 Million - Nasdaq
Novartis is watching US reciprocal tariff policy 'very carefully', CEO says - Reuters
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - TradingView
Roche secures Zealand obesity drug candidate for up to $5.3 billion - Reuters
Med-tech sector starts strong, with $6.28B in 2025 financings - BioWorld MedTech
Kestra Medical stock surges on public debut (KMTS:NASDAQ) - Seeking Alpha
Basel Medical prices $8.8M IPO - BioWorld Online
Basel Medical Group Ltd Completes $8.82 Million IPO - TipRanks
Mahindra Launches two Electric Origin SUVs, the BE 6 & the XEV 9e for India, Available with Monroe Intelligent Suspension Technology - The Manila Times
Basel Medical Group Ltd Closes $8.82 Million Initial Public Offering on Nasdaq - Nasdaq
Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies - Yahoo Finance
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline - Seeking Alpha
Basel Medical Group Ltd Launches $8.82 Million IPO on Nasdaq - TipRanks
Basel Medical Group stock edges up 4% following U.S. IPO - MSN
Basel Medical Group Prices IPO At $4.00 Per Share, Raising $8.82Mln; Stock Down - Nasdaq
Basel Medical Group Prices US $8,820,000 Initial Public Offering - TradingView
Basel Medical prices IPO of over 2 million shares at $4.00 per share - Investing.com India
Why Basel Medical Group Ltd (NASDAQ:BMGL) Looks Like A Quality Company - Yahoo Finance
Basel Medical Prices IPO at $4.00-$5.00 Per Share (BMGL) - Defense World
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting—lessons from the MACUSTAR study | Eye - Nature
Roche Group's total sales 2006-2024 - Statista
Opening Day: LNG player Venture Global opens below reduced IPO price - TipRanks
Opening Day: Oilfield services provider Flowco jumps in market debut - Yahoo Finance
Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report - Pharmafile
Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech
Layoffs Continued Across Biopharma in 2024 - BioSpace
Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation - BMC Medicine
Johnson & Johnson in Switzerland - Johnson & Johnson
(PDF) Trust in the health care professional and health outcome: A meta-analysis - ResearchGate
Opening Day: Jinxin Technology, zSpace make public debut - Nasdaq
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis - Neurology® Journals
Roche enters into a definitive agreement to acquire Poseida - GlobeNewswire
Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies - Roche
Basel Medical Group Ltd Files for 2.5M Share IPO at $4-$5/sh - Investing.com
0.27%
5.16%
大文字化:
|
ボリューム (24 時間):